ARRB2 (β-arrestin 2) expression has been shown to modulate the growth of colorectal cancer [48], glioblastoma [49], lung cancer [50], ovarian cancer [51], and prostate cancer [52]. Here, ARRB2 is linked to prostate carcinoma.